0001062993-23-014996.txt : 20230718
0001062993-23-014996.hdr.sgml : 20230718
20230718163253
ACCESSION NUMBER: 0001062993-23-014996
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230714
FILED AS OF DATE: 20230718
DATE AS OF CHANGE: 20230718
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: D'Andrea Carrie
CENTRAL INDEX KEY: 0001977969
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35776
FILM NUMBER: 231094667
MAIL ADDRESS:
STREET 1: 3009, BOUL. DE LA CONCORDE EAST
STREET 2: SUITE 102
CITY: LAVAL
STATE: A8
ZIP: H7E 2B5
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acasti Pharma Inc.
CENTRAL INDEX KEY: 0001444192
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 3009, BOUL. DE LA CONCORDE EAST
STREET 2: SUITE 102
CITY: LAVAL
STATE: A8
ZIP: H7E 2B5
BUSINESS PHONE: 450-686-4555
MAIL ADDRESS:
STREET 1: 3009, BOUL. DE LA CONCORDE EAST
STREET 2: SUITE 102
CITY: LAVAL
STATE: A8
ZIP: H7E 2B5
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-07-14
0001444192
Acasti Pharma Inc.
ACST
0001977969
D'Andrea Carrie
C/O ACASTI PHARMA INC.
3009 BOUL. DE LA CONCORDE EAST SUITE 102
LAVAL
A8
H7E 2B5
QUEBEC, CANADA
0
1
0
0
VP Clinical Operations
0
Stock Options (Right to Buy)
2.64
2023-07-14
4
A
0
42000
0
A
2033-07-14
Class A Common Shares
42000
42000
D
Stock options granted on 07/14/2023 under the Acasti Pharma Stock Option Plan, which vest and become exercisable in equal quarterly installments over a period of 36 months.
/s/ Prashant Kohli, as attorney-in-fact
2023-07-18